CalciMedica, Inc. Common Stock (CALC) Stock Price

CALCStock
$0.5979.99%52W
Market Cap$18.07M
P/E
PEG Ratio
Div yield
Beta0.76

CALC Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-10.08%
Price vs S&P 500 (4W)-25.54%
VGM Score23.30

CALC Earnings Surprise History

Q2 25-0.40est. -0.35
Q3 25-0.52est. -0.41
Q4 25-0.69est. -0.41
Q1 260.30est. -0.28
Q2 26-0.45est. -0.29

CALC Analyst Recommendations

May 2026
Jun 2026
Jul 2026
Aug 2026
4.10
4.10
4.10
4.00

Industry Peers — Pharmaceuticals(571)

SymbolValue ScoreGrowth ScoreMomentum ScorePrice
CALCCalciMedica, Inc. Common Stock
D$0.59
LLYEli Lilly & Co.DBB$1233.66
JNJJohnson & JohnsonDCB$273.14
ABBVABBVIE INC.DCB$265.79
MRKMerck & Co., Inc.DCA$156.45
NVSNovartis AGCCC$159.98
AZNAstraZeneca PLCCBC$169.66
NVONovo-Nordisk A/SBCC$48.66
ABTAbbott LaboratoriesCCB$116.13
PFEPfizer Inc.CDC$28.57
VRTXVertex Pharmaceuticals IncDCB$552.85

About CalciMedica, Inc. Common Stock

CalciMedica is a clinical-stage biopharmaceutical company developing treatments for serious inflammatory and immune-mediated diseases. Its lead candidate, Auxora, is a CRAC channel inhibitor designed to reduce inflammation and cellular damage in organs including the pancreas, lungs, and kidneys. Preclinical studies suggest potential therapeutic benefit for conditions driven by inflammatory and immune dysfunction.